NASDAQ:QDEL QuidelOrtho (QDEL) Stock Price, News & Analysis $43.45 -1.05 (-2.36%) (As of 09/6/2024 ET) Add Compare Share Share Today's Range$42.92▼$45.0750-Day Range$29.96▼$45.0152-Week Range$29.74▼$77.86Volume651,086 shsAverage Volume1.05 million shsMarket Capitalization$2.91 billionP/E RatioN/ADividend YieldN/APrice Target$57.50 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Get QuidelOrtho alerts: Email Address QuidelOrtho MarketRank™ Stock AnalysisAnalyst RatingHold2.14 Rating ScoreUpside/Downside32.3% Upside$57.50 Price TargetShort InterestHealthy5.93% of Shares Sold ShortDividend StrengthN/ASustainability-2.61Upright™ Environmental ScoreNews Sentiment0.59Based on 8 Articles This WeekInsider TradingSelling Shares$82.70 M Sold Last QuarterProj. Earnings Growth87.57%From $1.77 to $3.32 Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.4.59 out of 5 starsMedical Sector76th out of 910 stocksDiagnostic Substances Industry2nd out of 14 stocks 3.1 Analyst's Opinion Consensus RatingQuidelOrtho has received a consensus rating of Hold. The company's average rating score is 2.14, and is based on 3 buy ratings, 2 hold ratings, and 2 sell ratings.Amount of Analyst CoverageQuidelOrtho has only been the subject of 2 research reports in the past 90 days.Read more about QuidelOrtho's stock forecast and price target. Previous Next 4.0 Short Interest Percentage of Shares Shorted5.93% of the outstanding shares of QuidelOrtho have been sold short.Short Interest Ratio / Days to CoverQuidelOrtho has a short interest ratio ("days to cover") of 3.4, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in QuidelOrtho has recently decreased by 10.79%, indicating that investor sentiment is improving significantly. Previous Next 0.0 Dividend Strength Dividend YieldQuidelOrtho does not currently pay a dividend.Dividend GrowthQuidelOrtho does not have a long track record of dividend growth. Previous Next 3.8 Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreQuidelOrtho has received a 49.48% net impact score from Upright. The largest positive contribution comes from its "Physical diseases" impact, which is mostly driven by its "Sexually transmitted diseases quick tests", "Lactose intolerance quick tests", and "Respiratory tract infection tests" products. See details.Environmental SustainabilityThe Environmental Impact score for QuidelOrtho is -2.61. Previous Next 2.0 News and Social Media Coverage News SentimentQuidelOrtho has a news sentiment score of 0.59. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.News Coverage This WeekMarketBeat has tracked 8 news articles for QuidelOrtho this week, compared to 7 articles on an average week.Search InterestOnly 1 people have searched for QDEL on MarketBeat in the last 30 days. This is a decrease of -50% compared to the previous 30 days.MarketBeat FollowsOnly 1 people have added QuidelOrtho to their MarketBeat watchlist in the last 30 days. This is a decrease of -50% compared to the previous 30 days. Previous Next 2.5 Company Ownership Insider Buying vs. Insider SellingIn the past three months, QuidelOrtho insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $82,700,460.00 in company stock.Percentage Held by InsidersOnly 1.00% of the stock of QuidelOrtho is held by insiders.Percentage Held by Institutions99.00% of the stock of QuidelOrtho is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about QuidelOrtho's insider trading history. Previous Next 2.5 Earnings and Valuation Earnings GrowthEarnings for QuidelOrtho are expected to grow by 87.57% in the coming year, from $1.77 to $3.32 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of QuidelOrtho is -1.65, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of QuidelOrtho is -1.65, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioQuidelOrtho has a P/B Ratio of 0.58. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.Read more about QuidelOrtho's valuation and earnings. Previous Next See Top Rated MarketRank™ Stocks Here Ad Mode MobilePre-IPO| 32,481% Growth: First Disruption to $martphones in 15 Years🤳45M Users | 32,481% Growth Rate Get in on the biggest disruption to smartphones in over a decade. Reg A investment now open.Claim Exclusive 100% Bonus: $0.25/Share About QuidelOrtho Stock (NASDAQ:QDEL)QuidelOrtho Corporation provides diagnostic testing solutions. The company operates through Labs, Transfusion Medicine, Point-of-Care, and Molecular Diagnostics business units. The Labs business unit provides clinical chemistry laboratory instruments and tests that measure target chemicals in bodily fluids for the evaluation of health and the clinical management of patients; immunoassay laboratory instruments and tests, which measure proteins as they act as antigens in the spread of disease, antibodies in the immune response spurred by disease, or markers of proper organ function and health; testing products to detect and monitor disease progression across a spectrum of therapeutic areas; and specialized diagnostic solutions. The Transfusion Medicine business unit offers immunohematology instruments and tests used for blood typing to ensure patient-donor compatibility in blood transfusions; and donor screening instruments and tests used for blood and plasma screening for infectious diseases. The Point-of-Care business unit provides instruments and tests to provide rapid results across a continuum of point-of-care settings. The Molecular Diagnostics business unit offers polymerase chain reaction thermocyclers; amplification systems; and sample-to-result molecular instruments and tests for syndromic infectious disease diagnostics. The company sells its products directly to end users through a direct sales force; and through a network of distributors for professional use in physician offices, hospitals, clinical laboratories, reference laboratories, urgent care clinics, universities, retail clinics, pharmacies, wellness screening centers, blood banks, and donor centers, as well as for individual, non-professional, and over-the-counter use. It operates in North America, Europe, the Middle East, Africa, China, and internationally. The company was incorporated in 1979 and is headquartered in San Diego, California.Read More QDEL Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart QDEL Stock News HeadlinesAugust 10, 2024 | insidertrades.comInsider Selling: QuidelOrtho Co. (NASDAQ:QDEL) Major Shareholder Sells 78,180 Shares of StockAugust 8, 2024 | insidertrades.comQuidelOrtho Co. (NASDAQ:QDEL) Major Shareholder Sells $4,770,603.64 in StockSeptember 7, 2024 | Golden Crest (Ad)Biden's Successor: The Radical Threat to YOUR Savings!Kamala Harris isn't just playing politics; she's a serious threat to your financial security. Kamala has a plan to take over your money and leave you with nothing. Higher taxes, government control, and a digital dollar to track every penny you spend. This isn't about convenience; it's about CONTROL.September 6 at 6:35 PM | msn.comCraig-Hallum Upgrades QuidelOrtho (QDEL)September 6 at 5:59 AM | americanbankingnews.comQuidelOrtho (NASDAQ:QDEL) Upgraded to "Buy" at Craig HallumSeptember 6 at 12:54 AM | msn.comQuidelOrtho rises as Craig-Hallum upgrades on earnings powerSeptember 5 at 5:25 PM | fool.comWhy QuidelOrtho Stock Blasted 10% Higher TodayAugust 31, 2024 | americanbankingnews.comQuidelOrtho Co. (NASDAQ:QDEL) Receives $57.60 Consensus Price Target from BrokeragesSeptember 7, 2024 | Golden Crest (Ad)Biden's Successor: The Radical Threat to YOUR Savings!Kamala Harris isn't just playing politics; she's a serious threat to your financial security. Kamala has a plan to take over your money and leave you with nothing. Higher taxes, government control, and a digital dollar to track every penny you spend. This isn't about convenience; it's about CONTROL.August 29, 2024 | uk.finance.yahoo.comVITROS® Syphilis Assay Now Available on VITROS 3600 Immunodiagnostic System, VITROS 5600 and VITROS XT 7600 Integrated Systems in the U.S.August 23, 2024 | msn.comU.S. to restart free COVID test program as cases spikeAugust 19, 2024 | uk.finance.yahoo.comQuidelOrtho to Participate in Upcoming Investor ConferencesAugust 9, 2024 | globenewswire.comQUIDELORTHO ALERT: Bragar Eagel & Squire, P.C. is Investigating QuidelOrtho Corporation on Behalf of Long-Term Stockholders and Encourages Investors to Contact the FirmAugust 9, 2024 | finance.yahoo.comShareholders in QuidelOrtho (NASDAQ:QDEL) are in the red if they invested three years agoAugust 5, 2024 | ca.finance.yahoo.comQDEL Aug 2024 45.000 putAugust 1, 2024 | insidermonkey.comQuidelOrtho Corporation (NASDAQ:QDEL) Q2 2024 Earnings Call TranscriptAugust 1, 2024 | gurufocus.comQ2 2024 QuidelOrtho Corp Earnings Call TranscriptAugust 1, 2024 | gurufocus.comQuidelOrtho Corp (QDEL) Q2 2024 Earnings Call Transcript Highlights: Revenue Meets Expectations ...See More Headlines Receive QDEL Stock News and Ratings via Email Sign-up to receive the latest news and ratings for QuidelOrtho and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings7/31/2024Today9/07/2024Next Earnings (Estimated)11/06/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Diagnostic substances Sub-IndustryHealth Care Supplies Current SymbolNASDAQ:QDEL CUSIP74838J10 CIK353569 Webwww.quidel.com Phone(800) 874-1517Fax858-453-4338Employees7,100Year Founded1979Price Target and Rating Average Stock Price Target$57.50 High Stock Price Target$76.00 Low Stock Price Target$37.00 Potential Upside/Downside+32.3%Consensus RatingHold Rating Score (0-4)2.14 Research Coverage7 Analysts Profitability EPS (Most Recent Fiscal Year)($26.39) Trailing P/E RatioN/A Forward P/E Ratio24.55 P/E GrowthN/ANet Income$-10,100,000.00 Net Margins-65.60% Pretax Margin-70.08% Return on Equity3.87% Return on Assets2.09% Debt Debt-to-Equity Ratio0.70 Current Ratio1.44 Quick Ratio0.79 Sales & Book Value Annual Sales$2.83 billion Price / Sales1.03 Cash Flow$11.32 per share Price / Cash Flow3.84 Book Value$74.92 per share Price / Book0.58Miscellaneous Outstanding Shares66,972,000Free Float66,302,000Market Cap$2.91 billion OptionableOptionable Beta0.08 Social Links The Next 7 Blockbuster Stocks for Growth InvestorsWondering what the next stocks will be that hit it big, with solid fundamentals? Click the link below to learn more about how your portfolio could bloom.Get This Free Report Key ExecutivesMr. Joseph M. Busky CPA (Age 56)Chief Financial Officer Comp: $890.63kMr. Robert J. Bujarski J.D. (Age 55)Executive VP & COO Comp: $961.26kDr. Werner Kroll Ph.D. (Age 67)Senior Vice President of Research & Development Comp: $1.03MMr. Michael S. Iskra (Age 54)Executive VP & Chief Commercial Officer Comp: $870.93kMr. Brian J. Blaser (Age 59)President, CEO & Director Ms. Louise M. Brandy (Age 65)Chief Information Officer Ruben ArguetaDirector of Investor RelationsMs. Michelle A. Hodges J.D. (Age 61)Senior VP, General Counsel & Corporate Secretary Comp: $1.8MMr. William J. Ferenczy (Age 68)Point of Care Business Unit Leader Ms. Tamara A. Ranalli (Age 51)Molecular Diagnostics Business Unit Leader More ExecutivesKey CompetitorsMeridian BioscienceNASDAQ:VIVOHeskaNASDAQ:HSKAMerit Medical SystemsNASDAQ:MMSIDENTSPLY SIRONANASDAQ:XRAYICU MedicalNASDAQ:ICUIView All CompetitorsInsiders & InstitutionsTeachers Retirement System of The State of KentuckySold 10,766 shares on 8/26/2024Ownership: 0.028%Clearline Capital LPSold 285,683 shares on 8/16/2024Ownership: 0.458%Systematic Financial Management LPSold 52,204 shares on 8/16/2024Ownership: 0.211%Algert Global LLCBought 450 shares on 8/16/2024Ownership: 0.070%Susquehanna International Group LLPSold 18,700 shares on 8/16/2024Ownership: 0.000%View All Insider TransactionsView All Institutional Transactions QDEL Stock Analysis - Frequently Asked Questions How have QDEL shares performed this year? QuidelOrtho's stock was trading at $73.70 at the beginning of the year. Since then, QDEL stock has decreased by 41.0% and is now trading at $43.45. View the best growth stocks for 2024 here. How were QuidelOrtho's earnings last quarter? QuidelOrtho Co. (NASDAQ:QDEL) issued its quarterly earnings data on Wednesday, July, 31st. The company reported ($0.07) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.22) by $0.15. The business's revenue was down 4.2% on a year-over-year basis. What is Doug Bryant's approval rating as QuidelOrtho's CEO? 47 employees have rated QuidelOrtho Chief Executive Officer Doug Bryant on Glassdoor.com. Doug Bryant has an approval rating of 76% among the company's employees. Who are QuidelOrtho's major shareholders? QuidelOrtho's top institutional shareholders include Carlyle Group Inc. (17.20%), Rubric Capital Management LP (5.44%), Maverick Capital Ltd. (2.58%) and Dimensional Fund Advisors LP (1.90%). Insiders that own company stock include Carlyle Group Inc, Joseph M Busky and Mary Lake Ph D Polan. View institutional ownership trends. How do I buy shares of QuidelOrtho? Shares of QDEL stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. What other stocks do shareholders of QuidelOrtho own? Based on aggregate information from My MarketBeat watchlists, some other companies that QuidelOrtho investors own include NVIDIA (NVDA), DocuSign (DOCU), Tesla (TSLA), PayPal (PYPL), Shopify (SHOP), Block (SQ) and Teladoc Health (TDOC). This page (NASDAQ:QDEL) was last updated on 9/7/2024 by MarketBeat.com Staff From Our PartnersPerfect Crypto Buying Opportunity for 50 CentsWhen cryptos take a hit, the mom and pop investors run for the hills. But the top investors keep buying wit...Crypto 101 Media | SponsoredThe solution to fast food’s wage hike crisisShake Shack will be closing six California locations in response to the recent $20/hour minimum wage increase,...Deal Maker | SponsoredPre-IPO| 32,481% Growth: First Disruption to $martphones in 15 Years🤳45M Users | 32,481% Growth Rate Get in on the biggest disruption to smartphones in over a decade. Reg A inv...Mode Mobile | SponsoredBiden’s Capital Gains Tax to Devastate Savings!Don't let the corrupt elites dictate your future—ACT NOW! This guide is your first step towards financial inde...Golden Crest | SponsoredSay Goodbye to the US DollarThe warning signs are everywhere… According to experts, the United States Dollar is "as good as doomed." ...Sasco Gold LLC | SponsoredChina Stockpiling Gold “Like No Tomorrow”For 18 consecutive months, China’s central bank has increased its gold reserve. The country, with a populat...True Gold Republic | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredTrump’s weapon lurks in abandoned AmericaUnemployment is sky-high, wages are at record lows. Addiction has overwhelmed these once thriving coal towns. ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding QuidelOrtho Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share QuidelOrtho With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.